Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

Cybersecurity in LTC: Today’s Threat Landscape & Practical Defense | FrameworkFocus™ Jan 21, 2026

Show notes

Cyber threats facing long-term care pharmacies continue to evolve, putting sensitive data, systems, and patient trust at risk. In this episode of FrameworkFocus, host Todd Eury sits down with Scott Beatty, President & CEO of SoftWriters, and Chris Callahan of Echelon Risk + Cyber to explore today’s threat landscape and practical strategies to strengthen cybersecurity maturity. From leadership accountability to real-world defense tactics, discover how pharmacies can improve security hygiene and build resilience without slowing innovation.

What’s New in Diabetes Care for Older Adults? A Standards of Care 2026 Update | Geriatric Pharmacy Focus Jan 20, 2026

Show notes

The American Diabetes Association's 2026 Standards of Care in Diabetes are here! Let’s talk about what’s changed and how to better care for our older adults living with diabetes.
2026 Standards of Care in Diabetes: https://diabetesjournals.org/care/issue/49/Supplement_1
Tamara Ruggles, PharmD, BCGP, FASCP: www.linkedin.com/in/tamara-ruggles-491882251
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES: https://www.linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426/

Reduce Inflammation with Science-Backed Natural Solutions with Samuel Shepherd - Part 2 | Holistic Pharmacy Podcast Jan 19, 2026

Show notes

I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer.
In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience.
Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery.
In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets.
Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience.
Connect with Samuel via:
Email: info@valasta.net
Website: ValAsta
FB: ValAsta
Youtube: @ValAsta
Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.
Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Pharmacy & Policy: The Power of Legislative Collaboration | Executive Dose Jan 15, 2026

Show notes

On today’s Executive Dose, host Stephen Beckman is joined by Representative Charity Grimm Krupa, who serves Pennsylvania’s 51st District in the House of Representatives, for a timely and insightful discussion on the evolving healthcare policy landscape in the Commonwealth. Together, they explore recent legislative developments in Pennsylvania that are shaping healthcare delivery, access, and affordability, with a particular focus on how state-level decisions often serve as early indicators for broader national trends.

Stephen and Representative Grimm Krupa also examine the ripple effects Pennsylvania healthcare policy can have beyond state borders, highlighting why pharmacists, healthcare leaders, and industry stakeholders across the country should be paying close attention. From regulatory considerations to workforce challenges and patient-centered care initiatives, this episode offers valuable perspective on the intersection of policy, leadership, and healthcare innovation—and what it could mean for the future of healthcare nationwide.

Reduce Inflammation with Science-Backed Natural Solutions with Samuel Shepherd - Part 1 | Holistic Pharmacy Podcast Jan 14, 2026

Show notes

I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer.
In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience.
Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery.
In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets.
Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience.
Connect with Samuel via:
Email: info@valasta.net
Website: ValAsta
FB: ValAsta
Youtube: @ValAsta
Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.
Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Opioidology Part 3: Opioid-Philia vs Opioid-Phobia | Pain Pod Jan 12, 2026

Show notes

Opioidology Part 3: Opioid-Philia vs Opioid-Phobia
The often-blurred lines of pain, addiction, and substance use need a deeper dive into the extremes of opioid-philia and opioid-phobia (building upon Opioidology Part 1: Our Opioid Story). Join Mark “Pain Guy” Garofoli and our two guests James Hackworth and Jim Potenziano to take that deeper dive based on their recent collaboration in the Frontiers in Pain Research article “The Burden of Acute Pain in the U.S. in the Wake of the Opioid Crisis”.
• Frontiers in Pain Research Article: https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2025.1642035/full
• Article Key Takeaways
• Rising Pain Prevalence
• Balancing Act—Opioid Utilization vs. Undertreatment
• Provider Reluctance to use opioids
• Patient Reluctance
• Massive Economic Impact
• Call for Innovation & Policy Reform
• Opioid Story charts: www.painguy.us

The Three Biggest Healthcare News of 2025| RxRated Podcast Jan 12, 2026

Show notes

In this episode of the Rated Rx Podcast, pharmacists break down the biggest healthcare news of 2025 and what it actually means for patients and clinicians 👀💊. You hear real pharmacist perspectives on artificial intelligence in healthcare, new federal plans to regulate AI, and why clinical judgment, patient trust, and human decision making still matter more than algorithms 🤖➡️🧠.
The conversation also dives into major vaccine policy changes, including updates to newborn hepatitis B vaccination recommendations and why shifts like this raise real concerns for public health 🧬🩺. The crew explains what these changes mean in practice, how misinformation spreads fast, and why prevention still saves lives.
Later, the episode tackles the explosion of GLP 1 weight loss medications like semaglutide and tirzepatide. You hear honest discussion about access, cost, compounding risks, and why obesity needs to be treated as a chronic disease instead of a personal failure ⚖️📈. This episode blends news, clinical insight, and real world experience to unpack where healthcare is heading next.
This podcast is intended for entertainment and informational purposes only.
Listen and Follow Rated Rx 🎙️
Apple Podcasts
https://podcasts.apple.com/us/podcast/the-rated-rx-podcast/id1804181016
Spotify
https://open.spotify.com/show/7KATtG1c3HwwYpVMtRuNub
Facebook
https://www.facebook.com/profile.php?id=61574813907982
Instagram
https://www.instagram.com/ratedrxpodcast/
TikTok
https://www.tiktok.com/@ratedrxpodcast

The Season to Innovate: Strategic Legal and Regulatory Considerations for Approaching Acquisitions and Vetting AI Vendors | NASP Specialty Pharmacy Podcast Jan 09, 2026

Show notes

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles Health and Life Sciences Practice Group, and Amy Cotton Peterson, Partner at Quarles. As more automation solutions become available, its vital specialty pharmacy providers strategically approach acquisition of targets that offer technology and AI assets. This discussion explores effective diligence practices, common pitfalls, and risk mitigation strategies for specialty pharmacies navigating mergers and acquisitions and the rapidly evolving use of artificial intelligence.

Doing Things Differently: YARAL Pharma, Pennsylvania Policy, and the Birth Control Pharmacist | TWIRx Jan 09, 2026

Show notes

🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026
Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice.
✅ Today’s Sponsor: YARAL Pharma
YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace.
📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers.
https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill
2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care.
https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trusted
3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management.
https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html
4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide.
https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/
🎤 Interviews & Segments ⭐ Segment 1 — Special Sponsor Interview
Stephen Beckman, CEO of YARAL Pharma We kick off TWIRx with a special conversation featuring Stephen Beckman, CEO of YARAL Pharma, exploring what 2026 has in store for pharmacy and healthcare. We discuss the Pharmacy 50 Awards, the importance of honoring leadership across the profession, and why supporting pharmacists right now—during one of the most fragile and transformative moments in U.S. healthcare—is absolutely critical.
⭐ Featured Interview — Pennsylvania State Representative
Rep. Charity Grimm Krupa — 51st Legislative District Today’s featured interview is with State Representative Charity Grimm Krupa, who represents Pennsylvania’s 51st Legislative District in the House of Representatives. We discuss real healthcare issues impacting Pennsylvanians—including medical cannabis, small business healthcare benefit strategies, and why it’s essential for healthcare professionals to stay connected with their state lawmakers. Rep. Krupa also shares why every citizen should aim to communicate with their own representatives at least once per year.
⭐ Segment 2 — Clinical & Policy Spotlight
Dr. Sally Rafie, PharmD — “The Birth Control Pharmacist” In our second segment, we welcome Dr. Sally Rafie, PharmD, nationally known as the “Birth Control Pharmacist.” Dr. Rafie is a clinical pharmacist specialist at UC San Diego Health and an assistant clinical professor at the UC San Diego Skaggs School of Pharmacy, widely recognized for advancing pharmacists’ role in reproductive health care.
She is also the founder of Birth Control Pharmacist, an education and training company that equips pharmacists and healthcare teams to prescribe and deliver contraception care through evidence-based resources, clinical updates, and advocacy support—helping expand access to contraception through pharmacies nationwide.
🔔 Closing That wraps up this week’s episode of This Week in Pharmacy. Thanks for tuning in—and thank you again to YARAL Pharma for sponsoring today’s TWIRx. If you enjoyed today’s episode, please share it with a fellow pharmacist, leave a review, and stay connected as we continue to cover the stories shaping the pharmacy profession.
See you next week on TWIRx when we celebrate the "50 Most Influential People in Pharmacy" Awards LIVE!!

The Peptide Problem | Essential: The Pharmacy Compounding Podcast Jan 08, 2026

Show notes

In this edition of Essential, we’ve got concerns about the FDA’s revolving door, some issues with a new California law that might affects the whole country, and a new accreditation that might save a lot of headache. Then we take a deep dive into the once and future world of compounded peptides — where they are, and where they might be going … and why.
Links
FDA’s revolving door: https://archive.ph/oxBXP
Join APC today: https://a4pc.org/membership
Coalition for Compounding Excellence (CCE) accreditation: https://414uue.share-na2.hsforms.com/2n_hRAnRSQ4O8VteGTesF0Q?_hsenc=p2ANqtz-9rfyq3GuFFZw6omRa96tq_es549FWmjiw-sP5NU3LKrsL1eump-l18h7xVrvy8G_V1Pi4UFkfhARMnPCLIx7TBOwPClQ&_hsmi=394109070
Pharma Source Direct: https://www.linkedin.com/company/pharma-source-direct/

Related Podcasts